1
|
Mitsuboshi S, Yamaguchi R, Uchida H, Kamoshida S, Hashi H. Inappropriate use of ozone generators and their sales status: questionnaire survey of healthcare providers and investigation of online sales. J Hosp Infect 2021; 117:1-3. [PMID: 34375686 DOI: 10.1016/j.jhin.2021.07.010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2021] [Revised: 07/29/2021] [Accepted: 07/29/2021] [Indexed: 11/29/2022]
Abstract
Ozone generators have attracted attention as a result of the spread of severe acute respiratory syndrome coronavirus-2. In a questionnaire survey targeting healthcare facilities, 20 (91%) used ozone generators in patient areas, and five (23%) used them in indoor spaces occupied by people. A search for ozone generators on the Amazon Japan website revealed that 76% of products lacked information on ozone emission rate, coverage area and/or use time. These results suggest that ozone generators may be used inappropriately in hospitals and clinics, and have been sold to the general public without adequate information for assessing their safety and efficacy.
Collapse
Affiliation(s)
- S Mitsuboshi
- Department of Pharmacy, Kaetsu Hospital, Niigata, Japan.
| | - R Yamaguchi
- Department of Pharmacy, The University of Tokyo Hospital, Tokyo, Japan
| | - H Uchida
- Department of Pharmacy, Kanto Rosai Hospital, Kanagawa, Japan
| | - S Kamoshida
- Department of Pharmacy, Mito Brain Heart Centre, Ibaraki, Japan
| | - H Hashi
- Department of Pharmacy, Tokyo Bay Urayasu Ichikawa Medical Centre, Chiba, Japan
| |
Collapse
|
2
|
Okamura S, Osaki T, Nishimura K, Ohsaki H, Shintani M, Matsuoka H, Maeda K, Shiogama K, Itoh T, Kamoshida S. Thymidine kinase-1/CD31 double immunostaining for identifying activated tumor vessels. Biotech Histochem 2018; 94:60-64. [DOI: 10.1080/10520295.2018.1499962] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Affiliation(s)
- S. Okamura
- Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
| | - T. Osaki
- Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
| | - K. Nishimura
- Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
| | - H. Ohsaki
- Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
| | - M. Shintani
- Department of Medical Technology, Kobe Tokiwa University, Japan
| | - H. Matsuoka
- Department of Surgery, Fujita Health University School of Medicine
| | - K. Maeda
- Department of Surgery, Fujita Health University School of Medicine
| | - K. Shiogama
- Department of Morphology and Cell Function, Fujita Health University School of Health Sciences, Toyoake, Japan
| | - T. Itoh
- Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan
| | - S. Kamoshida
- Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, Kobe, Japan
| |
Collapse
|
3
|
Ogane N, Yasuda M, Kato H, Kato T, Yano M, Kameda Y, Kamoshida S. Cleaved caspase-3 expression is a potential prognostic factor for endometrial cancer with positive peritoneal cytology. Cytopathology 2018; 29:254-261. [DOI: 10.1111/cyt.12550] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 02/10/2018] [Indexed: 12/30/2022]
Affiliation(s)
- N. Ogane
- Department of Pathology; Kanagawa Prefectural Ashigarakami Hospital; Matsuda Japan
| | - M. Yasuda
- Department of Pathology; Saitama Medical University International Medical Center; Hidaka Japan
| | - H. Kato
- Department of Gynecology; Kanagawa Cancer Center; Yokohama Japan
| | - T. Kato
- Department of Pathology; Saitama Medical University International Medical Center; Hidaka Japan
| | - M. Yano
- Department of Pathology; Saitama Medical University International Medical Center; Hidaka Japan
| | - Y. Kameda
- Department of Pathology; Kanagawa Prefectural Ashigarakami Hospital; Matsuda Japan
| | - S. Kamoshida
- Department of Medical Biophysics; Laboratory of Pathology; Kobe University Graduate School of Health Sciences; Kobe Japan
| |
Collapse
|
4
|
Kamoshida S, Suzuki M, Shimomura R, Sakurai Y, Komori Y, Uyama I, Tsutsumi Y. Immunostaining of thymidylate synthase and p53 for predicting chemoresistance to S-1/cisplatin in gastric cancer. Br J Cancer 2007; 96:277-83. [PMID: 17211470 PMCID: PMC2360001 DOI: 10.1038/sj.bjc.6603546] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
High expression of thymidylate synthase (TS) and inactivation of p53 are allegedly associated with chemoresistance. The authors evaluated TS and p53 expression in gastric cancer treated with neoadjuvant S-1/cisplatin chemotherapy. Paraffin sections of pretreatment biopsy and surgical specimens from 41 gastric cancers were immunostained for TS and p53 protein after appropriate antigen retrieval. Fifty-one cases without neoadjuvant chemotherapy were also studied. In the pretreatment biopsies, high expression of TS was seen in 8% of the histologic responders, in 28% of the nonresponders and in 31% of the controls. High expression of p53 was observed in 56% of the nonresponders, but in 8% of the responders and in 29% of the controls (P<0.01 and P<0.05, respectively). The TS- and/or p53-high phenotype was seen in 76% of the nonresponders and in 54% of the controls, but in 8% of the responders (P<0.0001 and P<0.005, respectively). The data of the surgical specimens were consistent with those of the pretreatment biopsies. These results suggest that immunostaining for TS and p53 protein is useful for pretreatment selection of gastric cancer patients unresponsive to S-1/cisplatin chemotherapy.
Collapse
Affiliation(s)
- S Kamoshida
- Department of Pathology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan.
| | | | | | | | | | | | | |
Collapse
|
5
|
Watanabe A, Komine F, Nirei K, Tamura K, Nabe K, Aiba N, Kamoshida S, Otsuka M, Okubo H, Kanou M, Sawada S, Uchiyama T, Nakamura S, Arakawa Y. A case of secondary diabetes mellitus with acromegaly improved by pioglitazone. Diabet Med 2004; 21:1049-50. [PMID: 15317614 DOI: 10.1111/j.1464-5491.2004.01299.x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
AIM The acromegaly patient was diagnosed with Type 2 diabetes mellitus. His HbA1c was 10.6% and fasting blood glucose (FBG) 15.3 mmol/l. We prescribed glibenclamide (10 mg/day), but his HbA1c and FBG remained high. At this stage, treatment with short-acting insulin was instigated at a dose of 20 U/day. However, the patient's blood glucose level remained unsatisfactory. We tried using pioglitazone. METHOD Pioglitazone was prescribed at 30 mg/day in combination with the insulin. RESULTS The FBG and HbA1c value decreased to 7.2 mmol/l and 7.3%, respectively, within 2 months and insulin was discontinued. Pioglitazone alone was able to control the FBG level. CONCLUSIONS Pioglitazone treatment might be considered as a choice for similar cases of diabetes secondary to acromegaly.
Collapse
Affiliation(s)
- A Watanabe
- Third Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Kamoshida S, Satoh Y, Yasuda M, Kajiwara H, Tsukinoki K, Osamura RY. Immunohistochemical heterogeneity of type 1 blood group antigen expressions in testicular germ cell tumors. Oncol Rep 2002; 9:845-51. [PMID: 12066220 DOI: 10.3892/or.9.4.845] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022] Open
Abstract
The immunohistochemical expression of type 1 blood group antigens (type 1 BGAs) was analyzed for 30 cases of testicular germ cell tumors (TGCTs), using monoclonal antibodies against DU-PAN-2, CA19-9, Lewis(a) (Le(a)), and Lewis(b) (Le(b)). DU-PAN-2 was expressed very frequently in all of the embryonal carcinomas (ECs). CA19-9 expression was demonstrated in 53% of ECs, but the number of positive cells was generally smaller than that for DU-PAN-2. CA19-9-negative ECs tended to show a higher number of DU-PAN-2-positive cells compared to CA19-9-positive ECs, and ECs in which DU-PAN-2 was more strongly expressed showed a relatively frequent expression of CA19-9. In 36% of seminomas and 56% of yolk sac tumors (YSTs), DU-PAN-2 was weakly expressed, and the positive cells were few in number. Little or no expression of CA19-9 was demonstrated in seminomas and YSTs. Regarding Le(a) and Le(b), the expressions were found to be limited to teratomas at a frequency of 57% and 86%, respectively, with the exception of one EC positive for Lea and one YST positive for Leb. Eighty-six percent of teratomas showed expressions of DU-PAN-2 and CA19-9. DU-PAN-2 was also seen in some intratubular malignant germ cells. The antibodies used were all negative for choriocarcinomas, syncytiotrophoblastic giant cells, and normal testicular tissues. The antigen expressions were predominantly observed on the surface of tumor cells developing luminal structures. In conclusion, although CA19-9 was relatively specific for ECs, it should be emphasized that ECs were rather characteristic of extensive DU-PAN-2 expression. Particularly in CA19-9-negative ECs, a combined analysis of DU-PAN-2 and CA19-9 would be helpful in confirming the histopathologic diagnosis of TGCTs. The clinical significance of DU-PAN-2 in ECs as a tumor marker remains to be clarified. Le(a) and Le(b) expressions were thought to be related to the differentiation or maturation rather than to the malignant transformation in TGCTs.
Collapse
MESH Headings
- Adolescent
- Adult
- Antibodies, Monoclonal
- Antigens, Neoplasm/metabolism
- Biomarkers, Tumor/metabolism
- CA-19-9 Antigen/metabolism
- Carcinoembryonic Antigen/metabolism
- Carcinoma, Embryonal/immunology
- Carcinoma, Embryonal/metabolism
- Carcinoma, Embryonal/pathology
- Child
- Child, Preschool
- Endodermal Sinus Tumor/immunology
- Endodermal Sinus Tumor/metabolism
- Endodermal Sinus Tumor/pathology
- Female
- Humans
- Immunoenzyme Techniques
- Infant
- Infant, Newborn
- Lewis Blood Group Antigens/metabolism
- Male
- Middle Aged
- Neoplasms, Germ Cell and Embryonal/immunology
- Neoplasms, Germ Cell and Embryonal/metabolism
- Neoplasms, Germ Cell and Embryonal/pathology
- Orchiectomy
- Seminoma/immunology
- Seminoma/metabolism
- Seminoma/pathology
- Testicular Neoplasms/immunology
- Testicular Neoplasms/metabolism
- Testicular Neoplasms/pathology
Collapse
Affiliation(s)
- S Kamoshida
- Department of Pathology, Fujita Health University School of Medicine, Toyoake, Aichi 470-1192, Japan
| | | | | | | | | | | |
Collapse
|
7
|
Kamoshida S, Ogane N, Yasuda M, Muramatsu T, Bessho T, Kajiwara H, Osamura RY. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas. Mod Pathol 2000; 13:736-41. [PMID: 10912932 DOI: 10.1038/modpathol.3880127] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Immunohistochemical expressions of type 1 blood group antigens were studied for 95 cases of thyroid tumors, including 29 follicular adenomas, 23 follicular carcinomas, and 43 papillary carcinomas, applying monoclonal antibodies against DU-PAN-2, CA19-9, Lewis(a) (Le(a)), and Lewis(b) (Le(b)). Normal thyroid tissue invariably failed to express all four antigens. In follicular adenomas, DU-PAN-2 and CA19-9 were focally expressed in 7% and 21% of cases, and in follicular carcinomas, CA19-9 expression was limited to one case (4%); all cases were negative for DU-PAN-2. No or little expression of Le(a) or Le(b) was observed in these follicular tumors. In contrast, DU-PAN-2, CA19-9, Le(a), and Le(b) were expressed in 98%, 84%, 33%, and 49% of 43 papillary carcinomas, respectively. The positive stainings were observed mainly on the luminal surface of the tumor cells. The number of tumor cells that expressed DU-PAN-2 generally was greater than that of tumor cells that expressed CA19-9, Le(a), or Le(b). There was no significant difference in antigen expressions in female papillary carcinomas between subjects who were younger and older than 50 years old. The results suggest that DU-PAN-2 would be a useful immunohistochemical marker for distinguishing papillary carcinomas from follicular tumors. These immunohistochemical profiles imply the following: the activity of alpha2-3 sialyltransferase, a specific glycosyltransferase, would be more strongly enhanced in papillary carcinomas than in follicular tumors; the antigen expressions in papillary carcinomas may not be related to the alteration of the female sex hormone environment.
Collapse
MESH Headings
- Adenocarcinoma, Follicular/metabolism
- Adenocarcinoma, Follicular/pathology
- Adenoma/metabolism
- Adenoma/pathology
- Adult
- Aged
- Aged, 80 and over
- Antigens, Neoplasm/biosynthesis
- Biomarkers, Tumor/metabolism
- CA-19-9 Antigen/biosynthesis
- Carcinoma, Papillary/metabolism
- Carcinoma, Papillary/pathology
- Female
- Fluorescent Antibody Technique, Indirect
- Humans
- Male
- Middle Aged
- Thyroid Neoplasms/metabolism
- Thyroid Neoplasms/pathology
- Thyroiditis, Autoimmune/metabolism
- Thyroiditis, Autoimmune/pathology
Collapse
Affiliation(s)
- S Kamoshida
- Division of Pathology, Isehara Kyodo Hospital, Japan
| | | | | | | | | | | | | |
Collapse
|
8
|
Tazawa K, Kurihara Y, Kamoshida S, Tsukada K, Tsutsumi Y. Localization of prostate-specific antigen-like immunoreactivity in human salivary gland and salivary gland tumors. Pathol Int 1999; 49:500-5. [PMID: 10469392 DOI: 10.1046/j.1440-1827.1999.00900.x] [Citation(s) in RCA: 21] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Immunoreactivity of prostate-specific antigen (PSA), a kallikrein-like enzyme present in the seminal plasma, was demonstrated by indirect immunoperoxidase staining using a PSA antiserum in the apical cytoplasm along the luminal border of small-sized duct epithelial cells of the major salivary (parotid and submandibular) gland of both sexes (56/56, 100%). No PSA-like immunoreactivity was seen in large-sized duct epithelial cells and acinar cells. Minor salivary gland ducts were negative. When inflammatory and atrophic changes were observed, ductal expression of PSA-like immunoreactivity was decreased (12/37, 32%) and the site of intracellular localization often became diffusely cytoplasmic. The immunoreactivity was absorbed by human seminal plasma. Immunoreactivities of prostatic acid phosphatase and sex hormone receptors were undetectable in the salivary gland. Twenty-nine (34%) of 86 salivary gland tumors with ductal differentiation were immunoreactive for PSA mainly in the cytoplasm. A PSA monoclonal antibody ER-PR8 detected immunoreactivity in the prostate but not in the salivary glands or their tumors. Prostate-specific antigen-like immunoreactivity in small-sized (intercalated) duct epithelial cells of the major salivary gland and their tumors may be due to cross-reactivity of the antiserum with kallikrein-like substances.
Collapse
Affiliation(s)
- K Tazawa
- Department of Pathology, Tokai University School of Medicine, Bohseidai, Isehara, Japan
| | | | | | | | | |
Collapse
|
9
|
Kamoshida S, Saito E, Fukuda S, Kato K, Iwasaki A, Arakawa Y. Anatomical location of enterochromaffin-like (ECL) cells, parietal cells, and chief cells in the stomach demonstrated by immunocytochemistry and electron microscopy. J Gastroenterol 1999; 34:315-20. [PMID: 10433005 DOI: 10.1007/s005350050267] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Enterochromaffin-like (ECL) cells are included in the endocrine cells present in the gastric oxyntic mucosa, and have been attracting attention as histamine-secreting cells contributing to gastric secretion. However, the anatomical location of ECL cells in relation to parietal cells and chief cells has not yet been sufficiently investigated. To elucidate this location of ECL cells, we performed an immunocytochemical study using anti-histamine antibody and electron microscopic examination of guinea pig gastric mucosa. ECL cells were located near the basement membranes in the gastric oxyntic region, and were in contact with both chief cells and parietal cells in the same glandular epithelium. The ratio of ECL cells in contact with chief cells was clearly greater than that in contact with parietal cells. An omega-shaped morphology, indicating emiocytosis, was found in ECL cells by electron microscopy. These findings suggest that ECL cells have a paracrine effect on chief cells and parietal cells, and may have an important physiological role in pepsinogen secretion.
Collapse
Affiliation(s)
- S Kamoshida
- Third Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan
| | | | | | | | | | | |
Collapse
|
10
|
Kamoshida S, Satoh Y, Kamiya S, Tsutsumi Y. Heat shock protein 60 (HSP60) immunoreactivity in gastric epithelium associated with Helicobacter pylori infection: a pitfall in immunohistochemically interpreting HSP60-mediated autoimmune responses. Pathol Int 1999; 49:88-90. [PMID: 10227731 DOI: 10.1046/j.1440-1827.1999.00828.x] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Previous studies have suggested that heat shock proteins (HSP) of Helicobacter pylori (H. pylori) are involved in the induction of autoimmunity mediated gastritis. In the present report, the cross-reactivity between H. pylori-related HSP60 and gastric epithelial cells was investigated by the indirect immunoperoxidase method using two monoclonal antibodies (mAb) against H. pylori-derived HSP60, H9 and H20. H9 is reactive with an epitope common to bacterial HSP60, while H20 is specific to H. pylori HSP60. A total of 70 paraffin-embedded gastric biopsy specimens were analyzed after heat-induced epitope retrieval. Both mAb were cross-reactive with the gastric epithelial cells, with a higher frequency seen for the H9-reactive epitope. The frequency of positive epithelial decoration was not significantly different between H. pylori-positive and H. pylori-negative gastric mucosae. A variety of epithelial and non-epithelial cells were immunostained with mAb H9, while mAb H20 was cross-reactive only with small intestinal epithelia. Reactivity was mainly located in the Golgi area and rarely in the cytoplasm. These results suggest a noteworthy pitfall in immunohistochemical interpretations of HSP60-associated autoimmune reactions in the gastric mucosa.
Collapse
|
11
|
Kamoshida S, Tsutsumi Y. Expression of MUC-1 glycoprotein in plasma cells, follicular dendritic cells, myofibroblasts and perineurial cells: immunohistochemical analysis using three monoclonal antibodies. Pathol Int 1998; 48:776-85. [PMID: 9788261 DOI: 10.1111/j.1440-1827.1998.tb03837.x] [Citation(s) in RCA: 13] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
Normal and malignant plasma cells (PC), follicular dendritic cells (FDC), myofibroblasts (MFB) and perineurial cells (PNC) were investigated for the expression of MUC-1 glycoprotein (MUC-1gp) by immunohistochemical and immunoelectron microscopic techniques using monoclonal antibodies E29, 115D8, DF3 and a combination of the three. MUC-1 glycoprotein-positive PC detected by the combined antibodies were frequently seen in a variety of pathological lesions tested, including chronic cervicitis, chronic synovitis, Hodgkin's disease, allergic rhinitis and sinusitis, tuberculous lymphadenitis, foreign body granuloma, multiple myeloma, and chronic tonsillitis. In the lesions containing MUC-1gp-positive PC, the infiltration of immunoglobulin (Ig) E PC and/or IgE-bound mast cells was significantly increased, but MUC-1gp-positive PC did not contain any specific immunoglobulin heavy or light chains. The findings suggest that the expression of MUC-1 gp in PC, although not restricted to IgE-class cells, may be induced in an allergic status. Plasma cells and PNC mainly reacted with the antibodies E29 and 115D8, while FDC and MFB were principally reactive with the antibody DF3. In some cases of multiple myeloma, the neoplastic PC were predominantly immunoreactive with DF3. The results indicate: (i) the epitopic variability of MUC-1gp molecules expressed on the non-epithelial cells; and (ii) the epitopic alterations during malignant transformation. It should also be noted that the expression of MUC-1gp in the non-epithelial cells represents a pitfall in histopathological diagnosis.
Collapse
Affiliation(s)
- S Kamoshida
- Division of Pathology, Isehara Kyodo Hospital, Japan
| | | |
Collapse
|
12
|
Tokumoto H, Nomura S, Yamaguchi K, Yoshizumi M, Kamoshida S. [Primary pulmonary hemangiopericytoma detected on routine chest X-ray examination]. Nihon Kyobu Shikkan Gakkai Zasshi 1996; 34:1125-9. [PMID: 8953908] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Hemangiopericytoma is a rare tumor originating from pericytes. In May 1988, a 33-year-old man was found to have a well-defined nodular shadow in the right upper lobe during a routine chest X-ray examination. Although the mass had been thought to be benign, in December 1992 it was found to have grown. In May 1993, the patient was referred to our hospital for further examination. A chest X-ray film and a high-resolution CT scan revealed a well-defined nodule in the right upper lung field without vascular gathering or pleural puckering. The tumor was slightly less dense than was soft tissues. There was no evidence suggesting another primary tumor or metastasis. In July 1993, because the mass was suspected to be a low-grade malignant tumor, a segementectomy (rt-S2) was done. On the basis of histologic, immunohistochemical and electronmicroscopic findings, pulmonary hemangiopericytoma was diagnosed. The postoperative course was uneventful. The patient has been well for 2 years and five months after the operation, with no sign of recurrence or metastasis.
Collapse
Affiliation(s)
- H Tokumoto
- Department of Internal Medicine, Hyogo Prefectural Amagasaki Hospital, Japan
| | | | | | | | | |
Collapse
|
13
|
Kamoshida S, Tsutsumi Y. Extraprostatic localization of prostatic acid phosphatase and prostate-specific antigen: distribution in cloacogenic glandular epithelium and sex-dependent expression in human anal gland. Hum Pathol 1990; 21:1108-11. [PMID: 1699876 DOI: 10.1016/0046-8177(90)90146-v] [Citation(s) in RCA: 101] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Immunoreactivities of prostatic acid phosphatase (PACP) and prostate-specific antigen (PSA) were demonstrated in normal anal glands of males (11 of 25) and urethral glands of both sexes (six of six), by indirect immunoperoxidase staining. These prostatic antigens were colocalized in nonmucous epithelial cells. In the anal gland, PACP and PSA were distributed exclusively in acinus-forming, tall columnar cells, while columnar cells with brush borders, goblet cells, and transitional cells in the duct were negative. The anal glands from 20 females were devoid of such acinar structures and were negative for the antigens. Normal urinary bladder mucosa (n = 17) lacked immunoreactivity. A few endocrine-type cells, which showed PACP immunoreactivity but no PSA staining, were identified in normal rectal mucosa (n = 17) and were found rarely in the anal gland. The results of the present study suggest (1) that the development of acinar cells in the anal gland is an androgen-dependent phenomenon, and (2) that the ability to express PACP and PSA is a feature common to cloacogenic glandular epithelium.
Collapse
Affiliation(s)
- S Kamoshida
- Laboratory of Pathology, Isehara Kyodo Hospital, Japan
| | | |
Collapse
|
14
|
Tsutsumi Y, Kamoshida S, Iguchi K, Mochizuki T, Yanaihara N. Is helodermin-like immunoreactivity in human thyroid C cells due to a salmon calcitonin-like substance? Regul Pept 1990; 31:11-21. [PMID: 2270315 DOI: 10.1016/0167-0115(90)90191-x] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Helodermin-like and salmon calcitonin (sCT)-like immunoreactivities co-existed in a subset of human calcitonin (hCT)-containing cells in normal human thyroid tissue and medullary thyroid carcinomas. Helodermin/sCT-immunoreactive cells were mostly different from calcitonin gene-related peptide (CGRP)-positive cells. Helodermin and sCT immunoreactivities were not identified in pulmonary and pancreatic hCT-positive neuroendocrine tumors, except for a few lung tumor cells showing positive staining with one of two sCT antisera used. Helodermin immunoreactivity demonstrated by rabbit antiserum R0086 was completely abolished in the presence of synthetic sCT, while sCT immunoreactivity was not absorbed by synthetic helodermin. The carboxyl terminal Arg30-Thr31 sequence (and Pro35 amide structure) of helodermin would be the epitopic site recognized by this antiserum, since a similar amino acid sequence is present in sCT molecules but absent from hCT and CGRP.
Collapse
Affiliation(s)
- Y Tsutsumi
- Department of Pathology, Tokai University School of Medicine, Kanagawa, Japan
| | | | | | | | | |
Collapse
|
15
|
Kakudo K, Takami H, Katayama S, Matsuura N, Kamoshida S, Miyauchi A, Watanabe K. Carcinoembryonic antigen and nonspecific cross-reacting antigen in medullary carcinoma of the thyroid. Acta Pathol Jpn 1990; 40:261-6. [PMID: 2371832 DOI: 10.1111/j.1440-1827.1990.tb01560.x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Carcinoembryonic antigen (CEA) and nonspecific cross-reacting antigen (NCA) were studied immunohistochemically in formalin-fixed, paraffin-embedded tissues of 73 cases of medullary carcinoma of the thyroid (MTC) using 2 polyclonal antibodies (CEA antisera cross-reactive with or without NCA), 3 monoclonal antibodies recognizing epitopes only on CEA, and one monoclonal antibody against NCA. The staining patterns of the 5 antibodies against CEA in MTCs were not different, and they reacted with 86.3% of all cases. With regard to the effects of fixatives on the staining patterns, samples fixed with formalin or 4% paraformaldehyde demonstrated CEA immunoreactivity in both the cell membrane and cytoplasm. In Bouin-fixed tissue, the immunoreactivity was predominant on the cell membrane, whereas cytoplasmic positivity predominated in alcohol-fixed specimens. Thus the difference in fixatives used in previous studies does not appear to be a major reason for the difference in the reported incidence of CEA-positive MTCs. It is concluded that CEA is still a useful tumor marker for MTC and that it is detectable only in thyroid tumors originating from C cells, as seen in our series. The epitope defined by monoclonal antibody F106-88, present only on NCA, was found in 42.5% of all cases (49.2% of CEA-positive MTCs). The NCA immunoreactivity was located in the tumor cell cytoplasm as globular aggregates, which were also labeled for CEA.
Collapse
Affiliation(s)
- K Kakudo
- Department of Pathology, Tokai University School of Medicine, Isehara, Japan
| | | | | | | | | | | | | |
Collapse
|